News Details

Al Hammadi Announces the latest developments of the Memorandum of Understanding (MOU) signed with Sudair Pharma Company

In reference to the announcement of Al Hammadi Company for Development and Investment published on Tadawul website on 10/10/1439H corresponding to 24/06/2018G regarding the extension of the Memorandum of Understanding (MOU) signed on April 21, 2018 with Sudair Pharma Company for the acquisition of an equity stake with the same terms and conditions until August 31, 2018. Al Hammadi announces that the Memorandum of Understanding (MOU) with Sudair Pharma has expired and will not be renewed due to the failure to reach a final agreement on some terms in Partners Agreement.